510(k) device
Tablo Hemodialysis System (PN-0008000, PN-0006000U)
Outset Medical, Inc. · Dialyzer, High Permeability With Or Without Sealed Dialysate System (KDI, Class II) · First FDA decision Dec 12, 2019, newest Jan 26, 2026Kidney failure and dialysis
Last checked: Nov 20, 2026Source: FDA, CMS, ClinicalTrials.gov, PubMed
FDA decisions
7
510(k) pathway
Device trials
5
Naming "Tablo Hemodialysis"
MAUDE reports
293
Brand "Tablo Hemodialysis", since 2015
PubMed studies
10
Mentioning "Tablo Hemodialysis"
AI summary across all sources
Written by AI from the FDA, CMS, ClinicalTrials.gov, MAUDE and PubMed data on this page, plus web searches for payment facts.
Product review deck
A slide deck reviewing Tablo Hemodialysis System (PN-0008000, PN-0006000U)
About ten slides on the technology, clinical evidence, regulatory history and commercialization, built with AI from the data on this page and web research, with sources. Download it as PowerPoint to edit or as PDF to share.
- Executive summary and key facts
- Technology, with pictures of the device
- Clinical evidence and trials
- Regulatory history and safety
- Reimbursement, market and competition
- Risks, outlook and sources
AI-written from public data and may contain mistakes. Check each fact against its source before relying on it. Not investment, legal, reimbursement or medical advice.
FDA decisions
The newest 6 of 7 decisions filed under this name.
K253412 · Decided Jan 26, 2026 · 118 days after receipt
Device type: Dialyzer, High Permeability With Or Without Sealed Dialysate System (KDI) · GI, Urology & Nephrology
5 more FDA decisions with a free account
Older decisions: K190793
Medicare coverage
National and local coverage documents whose titles match this device or its device type. Payment add-ons (NTAP, pass-through, TCET) and likely codes are covered in the summary above.
No Medicare coverage document has a title matching this device or device type. Many devices are paid under existing codes without one.
Clinical trials
Device studies on ClinicalTrials.gov that name "Tablo Hemodialysis", any status and sponsor, newest update first.
The Rogosin InstituteAcademic, hospital or other
NCT05540457 · 10 participants · Start Sep 22, 2022 · Primary completion Feb 9, 2024
Device: Intermittent Non-InvasiveBlood Pressure Monitor · For: End Stage Renal Disease; End Stage Renal Disease on Dialysis; Dialysis Hypotension and 1 more
Sites: New York, New York
4 more trials with a free account
Adverse event reports (MAUDE)
Reports received since 2015 naming the brand "Tablo Hemodialysis", and for the whole product code for context.
This brand
293 reports: 151 malfunction, 106 injury, 34 death
Whole product code KDI
25,025 reports: 21,247 malfunction, 2,993 injury, 752 death
Newest reports for this brand
- Tablo Hemodialysis SystemMalfunction
3010355846-2026-00178 · Received Oct 29, 2026 · Event dated Sep 30, 2026
Device type: Dialyzer, High Permeability With Or Without Sealed Dialysate System (KDI)
Device problem as coded: Thermal Decomposition of Device
Patient problem as coded: No Clinical Signs, Symptoms or Conditions
4 more reports with a free account
Recalls
From FDA's recall database. FDA lists each recalled product separately, so one recall can appear several times. A recall is often a correction or a labeling change, not a removal from the market.
Z-0019-2025 · Started Aug 1, 2024 · Posted by FDA Oct 3, 2024
Reason given: Blood leak sensor, a component of hemodialysis device, may show decreased sensitivity, at the lowest level, specified as 0.35 mL/min blood leak rate, which could delay triggering the ALARM_DIALYZER_BLOOD_LEAK alarm, if blood loss, less-than 300ml, occurs, the patient may experience hypotension, fatigue, cramps,...
Cause as FDA categorized it: Nonconforming Material/Component · Device type: Dialyzer, High Permeability With Or Without Sealed Dialysate System (KDI)
4 more recall records with a free account
Published research
The most relevant PubMed records for "Tablo Hemodialysis"[tiab]. The summary above synthesizes these.
- Intensive care unit improves dialysis care quality while reducing costs.
Nichols TG, Doman D, Mullen S, et al. · J Med Econ · 2024
- Safety and efficacy of the Tablo hemodialysis system for in-center and home hemodialysis.
Plumb TJ, Alvarez L, Ross DL, et al. · Hemodial Int · 2020Multicenter Study, Research Support, Non-U.S. Gov't
- Self-care training using the Tablo hemodialysis system.
Plumb TJ, Alvarez L, Ross DL, et al. · Hemodial Int · 2021Research Support, Non-U.S. Gov't
- Antibiotic dosing recommendations in critically ill patients receiving new innovative kidney replacement therapy.
Lewis SJ, Mueller BA · BMC Nephrol · 2024
- Utility of a water-sparing approach for reducing dialysate flow rates in hospitalized patients with kidney failure.
Parikh A, Drake K, Woda C, et al. · Int J Artif Organs · 2025Observational Study, Multicenter Study
- Severe methanol poisoning treated with a novel hemodialysis system: a case report, analysis, and review.
Illescas AC, Argyropoulos CP, Combs SA, et al. · Ren Replace Ther · 2021Case Reports
- Transforming Care: Insourcing Acute Care Dialysis Services to Improve Patient Care.
McGill B, Hinkle D, McMurray C, et al. · Am J Crit Care · 2026
- Patient-reported outcomes from the investigational device exemption study of the Tablo hemodialysis system.
Chertow GM, Alvarez L, Plumb TJ, et al. · Hemodial Int · 2020Multicenter Study, Research Support, Non-U.S. Gov't
- Results of human factors testing in a novel Hemodialysis system designed for ease of patient use.
Wilcox SB, Carver M, Yau M, et al. · Hemodial Int · 2016
- Extension of Tablo TrEatmeNt Duration (XTEND) study: successful 24 h prolonged therapy with Tablo in critical patients.
Zaman T, Moore K, Jellerson J, et al. · BMC Nephrol · 2022Research Support, Non-U.S. Gov't
Other devices of this type
Also filed under product code KDI.
- NxStage System One with Cartridge Express (CAR-170-E and CAR-172-E)Nxstage Medical, Inc. · 510(k) 2024
- Aquadex FlexFlow System 2.0Chf Solutions, Inc. · 510(k) 2020
- NxStage Cartridge Express with SpeedswapNxstage Medical, Inc. · 510(k) 2019
- Venofer PumpRenal Solutions, Inc. · 510(k) 2012
- multiFiltratePRO SystemFresenius Medical Care Renal Therapies Group, LLC · 510(k) 2026
- Elisio-HNipro Medical Corporation · 510(k) 2026
- FX CorAL 40Fresenius Medical Care Renal Therapies Group, LLC · 510(k) 2025
- FX CorAL 60 (F00012969)Fresenius Medical Care Renal Therapies Group, LLC · 510(k) 2025
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.